BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8479000)

  • 1. Effects of dietary variations on plasma concentrations of oral flukicides in sheep.
    Taylor SM; Mallon TR; Blanchflower J; Kennedy DG; Hewitt SA
    J Vet Pharmacol Ther; 1993 Mar; 16(1):48-54. PubMed ID: 8479000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diet on plasma concentrations of oral anthelmintics for cattle and sheep.
    Taylor SM; Mallon TR; Blanchflower WJ; Kennedy DG; Green WP
    Vet Rec; 1992 Mar; 130(13):264-8. PubMed ID: 1585617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of diet type on the plasma disposition of triclabendazole in goats.
    Gokbulut C; Karademir U; Boyacioglu M; Akar F
    Res Vet Sci; 2007 Jun; 82(3):388-91. PubMed ID: 17067647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of rafoxanide following intraruminal and intra-abomasal administration in sheep.
    Swan GE; Koeleman HA; Steyn HS; Mülders MS
    J S Afr Vet Assoc; 1999 Jun; 70(2):71-4. PubMed ID: 10855825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of feed quality on the kinetic disposition of orally administered triclabendazole in sheep.
    Oukessou M; Souhaili Z
    Vet Res Commun; 1998 Jun; 22(4):257-63. PubMed ID: 9686440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of rafoxanide in suckling and weaned lambs following oral administration.
    Swan GE; Mülders MS
    J S Afr Vet Assoc; 1993 Jun; 64(2):67-70. PubMed ID: 8410945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative pharmacokinetics of triclabendazole in camels and sheep].
    Oukessou M; Toutain PL; Galtier P; Alvinerie M
    Rev Elev Med Vet Pays Trop; 1991; 44(4):447-52. PubMed ID: 1843827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.
    Mestorino N; Formentini EA; Lucas MF; Fernandez C; Modamio P; Hernández EM; Errecalde JO
    Vet Res Commun; 2008 Jan; 32(1):21-33. PubMed ID: 17457687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the oral bioavailability of three rafoxanide formulations in sheep.
    Swan GE; Botha CJ; Taylor JH; Mülders MS; Minnaar PP; Kloeck A
    J S Afr Vet Assoc; 1995 Dec; 66(4):197-201. PubMed ID: 8691406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mixed or sequential grazing of cattle and sheep on the faecal egg counts and growth rates of weaned lambs when treated with anthelmintics.
    Marley CL; Fraser MD; Davies DA; Rees ME; Vale JE; Forbes AB
    Vet Parasitol; 2006 Nov; 142(1-2):134-41. PubMed ID: 16887269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular plasma disposition and salivary secretion of closantel and rafoxanide in sheep.
    Swan GE; Koeleman HA; Steyn HS; Mülders MS
    J S Afr Vet Assoc; 1999 Jun; 70(2):75-9. PubMed ID: 10855826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic interaction between oxfendazole and triclabendazole: In vitro biotransformation and systemic exposure in sheep.
    Viviani P; Lifschitz AL; Luque SE; Lloberas MM; Maté ML; Cardozo PA; Lanusse CE; Virkel GL
    Exp Parasitol; 2019 Sep; 204():107718. PubMed ID: 31201779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of feed type on the pharmacokinetic disposition of oxfendazole in sheep.
    Ali DN; Chick BF
    Res Vet Sci; 1992 May; 52(3):382-3. PubMed ID: 1620973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction.
    Lifschitz A; Virkel G; Ballent M; Sallovitz J; Lanusse C
    Vet J; 2009 Nov; 182(2):261-8. PubMed ID: 18640064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle.
    Rapic D; Dzakula N; Sakar D; Richards RJ
    Vet Rec; 1988 Jan; 122(3):59-62. PubMed ID: 3354156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep.
    Virkel G; Lifschitz A; Sallovitz J; Ballent M; Scarcella S; Lanusse C
    J Vet Pharmacol Ther; 2009 Feb; 32(1):79-86. PubMed ID: 19161459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and partitioning of closantel and rafoxanide in ruminal fluid of sheep.
    Swan GE; Oliver DW; Van Rensburg J; Steyn HS; Mülders MS
    Onderstepoort J Vet Res; 2000 Jun; 67(2):97-103. PubMed ID: 11028745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diet variations on the kinetic disposition of oxfendazole in sheep.
    Oukessou M; Chkounda S
    Int J Parasitol; 1997 Nov; 27(11):1347-51. PubMed ID: 9421722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of triclabendazole in rabbits.
    Alvarez-Bujidos ML; Ortiz AI; Negro A; Cubría JC; Ordóñez D
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Nov; 106(3):805-8. PubMed ID: 7905812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.